Anticorps Recombinant de lapin anti-DNMT3A

DNMT3A Recombinant Antibody for IHC, IF/ICC, FC (Intra), Indirect ELISA

Hôte / Isotype

Lapin / IgG

Réactivité testée

Humain

Applications

IHC, IF/ICC, FC (Intra), Indirect ELISA

Conjugaison

Non conjugué

CloneNo.

242257A9

N° de cat : 81474-6-PBS

Synonymes

242257A9, Cysteine methyltransferase DNMT3A, DNA (cytosine-5)-methyltransferase 3A, DNA MTase HsaIIIA, EC:2.1.1.-



Informations sur le produit

81474-6-PBS cible DNMT3A dans les applications de IHC, IF/ICC, FC (Intra), Indirect ELISA et montre une réactivité avec des échantillons Humain

Réactivité Humain
Hôte / Isotype Lapin / IgG
Clonalité Recombinant
Type Anticorps
Immunogène DNMT3A Protéine recombinante Ag15111
Nom complet DNA (cytosine-5-)-methyltransferase 3 alpha
Masse moléculaire calculée 912 aa, 102 kDa
Numéro d’acquisition GenBankBC043617
Symbole du gène DNMT3A
Identification du gène (NCBI) 1788
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Protein A purfication
Tampon de stockage PBS only
Conditions de stockageStore at -80°C. 20ul contiennent 0,1% de BSA.

Informations générales

DNA methylation in vertebrate animals is an epigenetic modification that is important for embryonic development, imprinting, and the inactivation of X chromosomes. DNA methylation is catalyzed by a family of DNA methyltransferases (DNMTs) that include the maintenance enzyme DNMT1 and de novo methyltransferases DNMT3a and DNMT3b. The overexpression of DNMT1, DNMT3a, and DNMT3b has been reported in various malignancies, including gastric, urothelial, and lung cancers, and may be related to tumorigenesis, tumor progression, and poor survival. Two isoforms of DNMT3a exist: the full-length DNMT3a, and the shorter form DNMT3a2 which lacks the N-terminal fragment. DNMT3a is expressed ubiquitously at low levels, while DNMT3a2 is specially expressed at high levels in embryonic stem cells and shows restricted expression in tissues known to undergo de novo methylation including testis and ovary. This antibody was raised against the N-terminal region of human DNMT3a.

{{ptg:RelatedPrimaryAntibodies}}